pGEX-6P-3-F37A+L196F+V252A+C253G-hADPRM
(Plasmid
#107163)
-
PurposeExpresses specific cyclic-ADP-ribose (cADPR) phosphohydrolase in Escherichia coli as a GST fusion protein that can be cut with PreScission(TM) protease to yield active enzyme
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 107163 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGEX-6P-3
-
Backbone manufacturerGE Healthcare
- Backbone size w/o insert (bp) 4946
- Total vector size (bp) 6008
-
Modifications to backboneNone
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameF37A+L196F+V252A+C253G-hADPRM GST-mutant cADPR phosphohydrolase gene
-
SpeciesSynthetic
-
Insert Size (bp)1062
-
GenBank IDMF447900.1
- Promoter tac
-
Tag
/ Fusion Protein
- GST (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SalI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer pGEX Fwd
- 3′ sequencing primer pGEX Rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGEX-6P-3-F37A+L196F+V252A+C253G-hADPRM was a gift from Jose Carlos Cameselle (Addgene plasmid # 107163 ; http://n2t.net/addgene:107163 ; RRID:Addgene_107163) -
For your References section:
Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn(2+)-dependent ADP-ribose/CDP-alcohol diphosphatase. Ribeiro JM, Canales J, Cabezas A, Rodrigues JR, Pinto RM, Lopez-Villamizar I, Costas MJ, Cameselle JC. Sci Rep. 2018 Jan 18;8(1):1036. doi: 10.1038/s41598-017-18393-9. 10.1038/s41598-017-18393-9 [pii] PubMed 29348648